Experimental Antiviral Drug Proves Dramatically Effective at Preventing and Treating COVID-19 – HospiMedica

Using a novel in vivo research model containing human lung tissue, scientists have demonstrated that a broad spectrum, experimental drug EIDD-2801 proved dramatically effective at preventing and treating SARS-CoV-2 infection in human tissue in the lab.Scientists at the University of North Carolina School of Medicine (Chapel Hill, NC, USA) tested how the orally administered experimental drug EIDD-2801 halts SARS-CoV-2 replication and prevents infection of human cells in a new in vivo model containing…

Click here to view the original article.